Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

INV 001

Drug Profile

INV 001

Alternative Names: INV-001; INV-10000001

Latest Information Update: 31 May 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Innovo Therapeutics
  • Class Skin disorder therapies; Small molecules
  • Mechanism of Action HSP47 heat-shock protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Scars
  • Preclinical Hypertrophic scars; Keloids

Most Recent Events

  • 14 Feb 2023 Phase-II clinical trials in Scars (Prevention) in South Korea (Topical) (NCT05838833)
  • 16 Dec 2022 Pharmacodynamics data from preclinical studies in Hypertrophic scar and Keloid released by Innovo Therapeutics (3740583
  • 16 Dec 2022 Innovo Therapeutics plans to initiate phase II trial in Hypertrophic scars and Keloids in fourth quarter of 2022 (Innovo Therapeutics pipeline, December 2022)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top